Corcept Therapeutics (NQ: CORT )
34.24
+0.36
(+1.06%)
Streaming Delayed Price
Updated: 11:42 AM EDT, Jul 22, 2024
Add to My Watchlist
Press Releases about Corcept Therapeutics![]() ![]() ![]() ![]() ![]()
Corcept Completes Enrollment in Phase 4 CATALYST Trial
April 29, 2024
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Corcept Appoints Roberto Vieira as President, Oncology
January 29, 2024
Via GlobeNewswire
![]() ![]()
Court Finds Corcept Therapeutics’ Patents Not Infringed
January 02, 2024
Via GlobeNewswire
![]() ![]()
Corcept Appoints Monica Tellado as President, Emerging Markets
November 01, 2023
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|